2006
DOI: 10.1212/01.wnl.0000240128.76399.fa
|View full text |Cite
|
Sign up to set email alerts
|

Risk of ischemic complications related to the intensity of triptan and ergotamine use

Abstract: In general practice, triptan overuse does not increase the risk of ischemic complications. Overuse of ergotamine may increase the risk of these complications, especially in those simultaneously using cardiovascular drugs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
67
0
1

Year Published

2006
2006
2015
2015

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 100 publications
(69 citation statements)
references
References 36 publications
1
67
0
1
Order By: Relevance
“…In recognition of the vasodilatory properties of CGRP, as well as concerns regarding the cardiovascular liabilities of the currently available ergot and triptan migraine treatments (MaassenVanDenBrink et al, 1998;Wammes-van der Heijden et al, 2006), multiple groups have conducted preclinical studies of the cardiovascular effects of CGRP receptor antagonism. There has been particular interest in the potential effect of CGRP receptor antagonism in the setting of myocardial ischemic injury, given that CGRP is stored in perivascular peripheral nerve terminals of sensory C-fibers in the heart and is released from activated peripheral nerve endings during myocardial ischemia (Franco-Cereceda and Liska, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…In recognition of the vasodilatory properties of CGRP, as well as concerns regarding the cardiovascular liabilities of the currently available ergot and triptan migraine treatments (MaassenVanDenBrink et al, 1998;Wammes-van der Heijden et al, 2006), multiple groups have conducted preclinical studies of the cardiovascular effects of CGRP receptor antagonism. There has been particular interest in the potential effect of CGRP receptor antagonism in the setting of myocardial ischemic injury, given that CGRP is stored in perivascular peripheral nerve terminals of sensory C-fibers in the heart and is released from activated peripheral nerve endings during myocardial ischemia (Franco-Cereceda and Liska, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…One exception is patients with known cardiovascular disease or significant cardiovascular risk factors because of the medication's vasoconstricting properties and the risk for ischemia. 3 Healthy patients who take these medications as prescribed are at low risk for developing adverse events. However, patients who experience refractory headaches may inadvertently overuse these agents in an attempt to reduce their pain and disability.…”
mentioning
confidence: 99%
“…Though alternatives such as progesterone-only oral contraceptives have not demonstrated any increased risk of stroke, further research is warranted. 71 While triptan use in migraine patients has been shown to be generally safe, 23,25 ergotamine use should be avoided in patients with migraines, both as a treatment for migraine and for other disorders. Patients with migraines and stroke should avoid triptans as well.…”
Section: Discussionmentioning
confidence: 99%